Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Girardi NI, Cushing MM. Pick Your Poison: Anemia or Transfusion. Ann Thorac Surg. 2023;116(5):1119.

Mlynarczyk C, Teater M, Pae J, Chin CR, Wang L, Arulraj T, et al. BTG1 mutation yields supercompetitive B cells primed for malignant transformation. Science. 2023;379(6629):eabj7412.

Thomas JL, Tee MW, Harp J, Magro C. Azathioprine hypersensitivity syndrome manifesting as subcutaneous Sweet syndrome and acute pancreatitis. J Cutan Pathol. 2023;50(2):127-130.

Pallasaho S, Gondane A, Kuivalainen A, Girmay S, Moestue S, Loda M, et al. Castration-resistant prostate cancer cells are dependent on the high activity of CDK7. J Cancer Res Clin Oncol. 2023;149(8):5255-5263.

Pitman MB, Centeno BA, Reid MD, Saeig M, Siddiqui MT, Layfield LJ, et al. A brief review of the WHO reporting system for pancreaticobiliary cytopathology. J Am Soc Cytopathol. 2023;12(4):243-250.

Adegbite BO, Abramson MH, Gutgarts V, Musteata MF, Chauhan K, Muwonge AN, et al. Dasatinib nephrotoxicity correlates with patient-specific pharmacokinetics. medRxiv. 2023.

González-Muñoz T, Di Giannatale A, García-Silva S, Santos V, Sánchez-Redondo S, Savini C, et al. Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Clin Cancer Res. 2023;29(18):3744-3758.

Setton J, Hadi K, Choo Z-, Kuchin KS, Tian H, Paula AD, et al. Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. Nature. 2023;621(7977):129-137.

Ma C, Wang X, Dai JY, Turman C, Kraft P, Stopsack KH, et al. Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study. Cancer Epidemiol Biomarkers Prev. 2023;32(10):1436-1443.

Boyraz B, Gogakos T, Raskin KA, Nielsen GP. Metastatic Uterine Leiomyosarcoma With Rhabdomyosarcomatous Heterologous Differentiation. Int J Gynecol Pathol. 2023;42(2):151-154.